Detalhe da pesquisa
1.
Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2).
Haematologica
; 108(9): 2331-2342, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951163
2.
Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML.
Blood
; 134(3): 263-276, 2019 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31076446
3.
Impact of secondary-type mutations in NPM1 mutated AML.
Eur J Haematol
; 111(1): 165-168, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37165755
4.
Impact of CD33 and ABCB1 single nucleotide polymorphisms in patients with acute myeloid leukemia and advanced myeloid malignancies treated with decitabine plus gemtuzumab ozogamicin.
Am J Hematol
; 95(9): E225-E228, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32356320
5.
Sudden blastic transformation in treatment-free remission chronic myeloid leukaemia.
Br J Haematol
; 187(4): 543-545, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31584727
6.
Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase.
Hematology
; 29(1): 2329027, 2024 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38526239
7.
Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN.
Blood Adv
; 8(5): 1281-1294, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38170760
8.
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.
Nat Med
; 28(3): 557-567, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35241842
9.
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse.
Blood Adv
; 5(20): 3913-3918, 2021 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34464974
10.
Validation, Implementation, and Clinical Impact of the Oncomine Myeloid Targeted-Amplicon DNA and RNA Ion Semiconductor Sequencing Assay.
J Mol Diagn
; 23(10): 1292-1305, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34365012
11.
Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience.
Blood Adv
; 5(23): 5415-5419, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34525185
12.
Unique case of ANCA-negative pauci-immune necrotizing glomerulonephritis with diffuse alveolar hemorrhage, potentially associated with midostaurin.
CEN Case Rep
; 9(2): 147-151, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31955389
13.
Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype.
Blood Cancer J
; 10(5): 47, 2020 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32366832
14.
Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia.
Clin Lymphoma Myeloma Leuk
; 20(4): 212-218, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32035785
15.
Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes.
Leukemia
; 34(3): 872-881, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31719677
16.
Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial.
Lancet Haematol
; 7(7): e523-e533, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32589978
17.
Venetoclax for the treatment of newly diagnosed acute myeloid leukemia in patients who are ineligible for intensive chemotherapy.
Ther Adv Hematol
; 10: 2040620719882822, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31692757
18.
Single-agent and combination biologics in acute myeloid leukemia.
Hematology Am Soc Hematol Educ Program
; 2019(1): 548-556, 2019 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31808888
19.
Recent Advances in Adult Acute Lymphoblastic Leukemia.
Curr Hematol Malig Rep
; 14(2): 106-118, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30879177
20.
Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol.
Leukemia
; 38(4): 912-913, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431747